John Peck
Directeur/Membre du Conseil chez Batu Biologics, Inc.
Fortune : 227 283 $ au 30/04/2024
Profil
John Peck is currently a Director at Batu Biologics, Inc. He holds an MBA from DePaul University and an undergraduate degree from Northern Illinois University, which he received in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2023 | 227 283 333 ( 5,37% ) | 227 283 $ | 30/04/2024 |
Postes actifs de John Peck
| Sociétés | Poste | Début |
|---|---|---|
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 24/02/2017 |
Formation de John Peck
| DePaul University | Masters Business Admin |
| Northern Illinois University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Batu Biologics, Inc.
Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Health Technology |